Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid as a Adjunct to Intravenous Tranexamic Acid in Adult Spinal Deformity Surgery
NCT03553186Phase 3Recruiting
- Sponsor
- Hospital for Special Surgery
- Start
- Jul 2018
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Spinal deformity and degenerative lumbar spinal stenosis (LSS) comparing ivTXA + topical TXA with IV TXA + topical placebo (2 arms). Primary endpoint: Postoperative Drain output at 48 hours. Started Jul 2018; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Spinal deformitydegenerative lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on NCT03553186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03553186.